According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

The number of patients who require maintenance on anticoagulation therapy (warfarin/Coumadin ®) for minimizing risk of cardiovascular events like stroke or thromboembolism is increasing.

Antiplatelets are particularly beneficial for people who have had a previous heart attack or stroke, those with CAD, or ...

Heparin bridging during the resumption of anticoagulation post-intracranial hemorrhage may be linked to an increased risk for bleeding.

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

CVKD READ THE FULL CVKD RESEARCH REPORT We are initiating coverage of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) with a $30.00 valuation. Cadrenal is a biopharmaceutical developing innovative therapies ...

In a recent study published in the scientific journal "Blood", researchers from MedUni Vienna show that hemorrhages are more common in cancer patients than previously thought and are associated with a ...

Brazilian researchers from UFRJ and INBEB uncover how mutant p53, a key tumor suppressor, transforms proteins like p63 and ...

CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new ...

Cases of atrial arrhythmia in patients with Duchenne muscular dystrophy (DMD) are common but lack a standard solution, and ...

Research from the Federal University of Rio de Janeiro (UFRJ) and the National Institute of Science and Technology for Structural Biology and ...